Leflunomide
Brand name: Leflunomide
Rank #463 of 500 drugs by total cost
$16.0M
Total Cost
205,765
Total Claims
$16.0M
Total Cost
3,273
Prescribers
$78
Cost per Claim
55,870
Beneficiaries
416,378
30-Day Fills
$4,875
Avg Cost/Provider
63
Avg Claims/Provider
About Leflunomide
Leflunomide (sold as Leflunomide) was prescribed 205,765 times by 3,273 Medicare Part D providers in 2023, costing the program $16.0M. At $78 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 460 | Letermovir (Prevymis) | $16.1M | 2,144 |
| 461 | Fluphenazine Hcl (Fluphenazine Hcl) | $16.0M | 73,051 |
| 462 | Nivolumab (Opdivo) | $16.0M | 1,275 |
| 463 | Leflunomide (Leflunomide) | $16.0M | 205,765 |
| 464 | Hydrocortisone (Hydrocortisone) | $15.9M | 762,398 |
| 465 | Digoxin (Digoxin) | $15.9M | 548,410 |
| 466 | Alpelisib (Piqray) | $15.7M | 747 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology